The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
Technion Eyal Zussman of the Faculty of Mechanical Engineering has developed a sticker for surgical masks that could improve safety for health care workers in dire need of effective personal protective equipment. It may look simple, but the sticker contains sophisticated technology to combat COVID-19. While existing masks worn to treat COVID-19 patients provide a first line of defense, tiny droplets carrying the highly contagious virus can still get through and infect the medical staff. Dubbed “Maya,” the new protective sticker is manufactured using a 3D printer and covers the outside of ordinary surgical masks. The sticker contains a nanofiber-based…
A team of scientists led by Technion Professor Naama Geva-Zatorsky is developing a kit that would allow for simple and inexpensive COVID-19 testing in the safety and comfort of your home, with results in under an hour. The kit could be critical in expanding the number of people who get tested, key to reopening the economy in the U.S. and Israel. Users immerse a saliva sample in a test tube with chemicals known as reagents and then into a cup of hot water. If the coronavirus is present, the color changes, no lab required. The test proved accurate in identifying…
Ifat Rubin-Bejerano holds a Ph.D. and a B.Sc. magna cum laude from the Technion and today serves as Director of Translational Research Programs at Harvard Medical School. She is also a member of the Massachusetts Consortium for Pathogen Readiness that is helping find and fund innovative solutions in the fight against COVID-19. Can you share a bit about your background? I was born and raised in Hod HaSharon, Israel. My father was an engineer, my mother was a teacher and I grew up with three sisters. Though Hod HaSharon is now very urbanized, when I was growing up it was…
Nothing’s out of reach when brilliant, entrepreneurial scientists set their minds on a common goal. The COVID-19 pandemic has sparked more than a dozen projects at the Joan & Irwin Jacobs Technion-Cornell Institute at Cornell Tech in New York City. Pressing pause on their work-a-day projects, students, faculty, and graduates of the Jacobs Technion-Cornell Institute and its Runway Startup Postdoc Program are developing coronavirus-related initiatives ranging from diagnostic tests and therapeutics to protective healthcare gear, and help in coping with isolation and fear. Case in point: In mid-March, just two weeks after the first confirmed case of coronavirus in New…
Dr. Eyal Zimlichman is the chief medical officer and chief innovation officer at Sheba (Tel Ha’Shomer) Medical Center in Israel, considered to be among the best hospitals in the world. Dr. Zimlichman is the founder and director of Sheba’s ARC innovation program, an open global innovation ecosystem that aims to redesign healthcare through digital health solutions by 2030. For these efforts, he was named as one of “Israel’s 100 Most Influential People This Jewish Year” by Israel’s leading financial newspaper, TheMarker, in 2019. Previously, Dr. Zimlichman served as lead researcher at Partners Healthcare’s clinical affairs department in Boston, where he advanced…
Following the spirit of Technion President Uri Sivan’s message of “community is immunity,” the Technion Student Association (TSA) has mobilized hundreds of students to minimize the human cost of COVID-19 in Israel. While coping with a rigorous academic workload as well as the hardships brought on by the coronavirus, the student volunteers are eagerly contributing their time and skills to help those most affected by the crisis. The efforts began in late February when approximately 15 students were self-quarantined in the dorms of Technion City. Many didn’t have family in Israel, so the TSA quickly stepped up to support them…
Technion Professor Josué Sznitman and his team have developed an innovative pulmonary treatment for treating Acute Respiratory Distress Syndrome (ARDS), which is recognized as the leading cause of mortality in COVID-19 patients. To date, there is no existing therapy to treat ARDS patients. These patients undergo assisted ventilation and oxygenation, oftentimes under intubation, in intensive care units. One of the hallmarks of ARDS is damage to pulmonary surfactant (the liquid that coats the surface of alveoli in the lungs). Surfactant has many roles, but perhaps most importantly it reduces the forces required for breathing. While research is ongoing to understand…
Professor Ezri Tarazi, chair of the Industrial Design Program and head of the Design-Tech Lab at the Technion – Israel Institute of Technology, together with doctors at the Clinical Research Institute at Rambam Health Care Campus, have developed a breakthrough device that dramatically improves the efficacy of protective masks worn by COVID-19 medical staff everywhere. Medical staff worldwide report that overheating and foggy glasses make it difficult for staff to care for COVID-19 patients. Body temperature often causes condensation to build up inside protective gear, which causes masks to fog up and makes it difficult for medical staff to see…
The World Health Organization (WHO) has named vaccine hesitancy — the reluctance or refusal to vaccinate despite the availability of vaccines — as one of the top 10 threats to global health. Online misinformation may compound the problem. Yet despite this risk, little research attention has been paid to understanding how individuals seek vaccine information online and evaluate its trustworthiness.
Researchers at the Technion and Rambam Health Care Campus have successfully tested a method that will dramatically increase the current COVID-19 testing capacity using existing available resources. This method, known as pooling, enables simultaneous testing of dozens of samples. Its implementation has the potential to greatly accelerate the rate of testing and detection of the population’s COVID-19-infected patients. The trial was completed in a matter of days thanks to the support of the Ministry of Health and the close collaboration between the Technion and Rambam. Testing for COVID-19 is currently being conducted in Israel with the focus on people with…
The technological revolution of the last several decades has brought about amazing advances in the way we live our lives. But now we have to step up the game. With the ever-increasing energy needs required to run the internet, and cybersecurity becoming a ubiquitous threat, the global science community is asking, “What new technology will further the path of unprecedented progress?” The Answer Is Quantum Technology Applications of quantum technology are leading to practical devices for computing, communication and sensing, and imaging devices. These applications are important not only for the development of new products, but also for the critical…
Researchers at the Technion, the Rambam Healthcare Campus (Rambam Medical Center), and colleagues at the McEwen Stem Cell Institute at the University Health Network in Toronto have succeeded in producing 3D engineered cardiac tissues from embedded chamber-specific heart cells (atrial and ventricular cells) derived from human stem cells. The tissues, which simulate heart tissues of the atrium (auricle, or the upper chamber of the heart through which blood enters the ventricles) or the ventricles, will serve in the near future for personalizing medications for cardiac patients and developing new drugs to treat them. In the more distant future, the technology…